z-logo
open-access-imgOpen Access
Antibiotic Dosing Discrepancies in the 2014 Skin and Soft Tissue Infections Guidelines
Author(s) -
Khalid Eljaaly,
Samah Alshehri,
Monica V. Mahoney
Publication year - 2015
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/civ123
Subject(s) - medicine , dosing , antibiotics , soft tissue , intensive care medicine , surgery , microbiology and biotechnology , biology
TO THE EDITOR—We read with interest the updated guidelines for the management of skin and soft tissue infections from the Infectious Diseases Society of America [1]. Their effort to expand on drug dosing is clear and appreciated. However, we would like to draw attention to a few dosing discrepancies. Table 3 [1] lists regimens for the treatment of intestinal or genitourinary tract infections following surgery. Ciprofloxacin is recommended in several instances at a dose of 400 mg IV every 12 hours or as the oral formulation at 750 mg PO every 12 hours. Based on drug bioavailability, an equivalent oral dose for 400 mg

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom